298
Views
4
CrossRef citations to date
0
Altmetric
Review

Combinations of chemo-, immuno-, and gene therapies using nanocarriers as a multifunctional drug platform

, , , , &
Pages 1337-1349 | Received 28 Mar 2022, Accepted 09 Aug 2022, Published online: 26 Sep 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Conor A. Ruzycki, Derek Montoya, Hammad Irshad, Jason Cox, Yue Zhou, Jacob D. McDonald & Philip J. Kuehl. (2023) Inhalation delivery of nucleic acid gene therapies in preclinical drug development. Expert Opinion on Drug Delivery 20:8, pages 1097-1113.
Read now

Articles from other publishers (3)

Hang Liu, Yelin Dai, Jia Li, Ping Liu, Wenhui Zhou, Deng-Guang Yu & Ruiliang Ge. (2023) Fast and convenient delivery of fluidextracts liquorice through electrospun core-shell nanohybrids. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Elizabeth C. H. T. Lau, Michelle Åhlén, Ocean Cheung, Alexey Y. Ganin, David G. E. Smith & Humphrey H. P. Yiu. (2023) Gold-iron oxide (Au/Fe3O4) magnetic nanoparticles as the nanoplatform for binding of bioactive molecules through self-assembly. Frontiers in Molecular Biosciences 10.
Crossref
Yufen Huang, Qinjie Kou, Yanrong Su, Lu Lu, Xisheng Li, Haiye Jiang, Rong Gui, Rong Huang, Xinmin Nie & Jian Li. (2023) Combination therapy based on dual-target biomimetic nano-delivery system for overcoming cisplatin resistance in hepatocellular carcinoma. Journal of Nanobiotechnology 21:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.